Skip to main content
Fig. 1 | Parasites & Vectors

Fig. 1

From: The therapeutic effect of larval saliva and hemolymph of Lucilia sericata on the treatment of Leishmania major lesion in BALB/c mice946

Fig. 1

Viability percentage of Leishmania major promastigotes treated with different concentrations of Lucilia sericata larval saliva and hemolymph compared with glucantime. a %Viability of L. major promastigotes treated with different concentrations of larval products at 24 h. b %Viability of L. major promastigotes treated with larval products at 48 h. c %Viability of L. major promastigotes treated with larval products at 72 h. d %Viability of L. major promastigotes treated with larval products at 96 h

Back to article page